Foghorn TherapeuticsFHTX
那斯達克 · USD
2.07
+0.02
(+0.98%)
收盤 11/14 04:59 (UTC+8)
11/14 04:59 (UTC+8)
Foghorn TherapeuticsFHTX
2.07
+0.02
(+0.98%)
財務數據
損益表
- 0.07
- 0.08
- 0.03
- 0.06
- 0.08
- 0.08
- 0.09
- 0.03
- 0.16
- 0.84
- 36.40
- 13.36
- -63.42
- 108.40
- 26.97
- 7.89
- 13.42
- -64.67
- 391.95
- 419.80
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q3 | 2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | |
營業收入淨額 | 83,543 | 16,072 | 3,267 | 9,247 | 8,153 | 7,557 | 5,952 | 2,856 | 7,808 | 6,888 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 83,543 | 16,072 | 3,267 | 9,247 | 8,153 | 7,557 | 5,952 | 2,856 | 7,808 | 6,888 |
營業費用 | 26,904 | 24,877 | 24,840 | 33,125 | 26,654 | 28,654 | 28,865 | 26,861 | 31,660 | 33,520 |
研發費用 | 18,836 | 18,523 | 18,259 | 22,046 | 20,002 | 21,792 | 21,626 | 20,508 | 24,689 | 23,797 |
推銷及管理費用 | 5,796 | 6,354 | 6,581 | 5,165 | 6,652 | 6,862 | 7,239 | 6,353 | 6,971 | 7,325 |
非經常性項目費用 | 2,272 | - | - | 5,914 | - | - | - | - | - | 2,398 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 56,639 | -8,805 | -21,573 | -23,878 | -18,501 | -21,097 | -22,913 | -24,005 | -23,852 | -26,632 |
其他收入及費用 | 1,511 | 1,614 | 1,698 | 2,214 | 2,652 | 3,161 | 4,079 | 4,502 | 4,730 | 3,653 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 58,150 | -7,191 | -19,875 | -21,664 | -15,849 | -17,936 | -18,834 | -19,503 | -19,122 | -22,979 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | 58,150 | -7,191 | -19,875 | -21,664 | -15,849 | -17,936 | -18,834 | -19,503 | -19,122 | -22,979 |
基本每股稅後盈餘(元) | 0.81 | -0.10 | -0.29 | -0.35 | -0.25 | -0.28 | -0.30 | -0.23 | -0.31 | -0.45 |
稀釋每股稅後盈餘(元) | 0.82 | -0.10 | -0.29 | -0.34 | -0.26 | -0.28 | -0.30 | -0.30 | -0.26 | -0.43 |
基本平均股數(千股) | 71460.00 | 70629.00 | 69540.00 | 63068.00 | 63029.00 | 62978.00 | 62848.00 | 62987.00 | 62602.00 | 51580.00 |
稀釋平均股數(千股) | 72590.00 | 70629.00 | 69540.00 | 63068.00 | 63029.00 | 62978.00 | 62848.00 | 62987.00 | 62602.00 | 51580.00 |
還原基本每股稅後盈餘(元) | 0.81 | -0.10 | -0.29 | -0.35 | -0.25 | -0.28 | -0.30 | -0.23 | -0.31 | -0.45 |
還原稀釋每股稅後盈餘(元) | 0.82 | -0.10 | -0.29 | -0.34 | -0.26 | -0.28 | -0.30 | -0.30 | -0.26 | -0.43 |
還原基本平均股數(千股) | 71,460 | 70,629 | 69,540 | 63,068 | 63,029 | 62,978 | 62,848 | 62,987 | 62,602 | 51,580 |
還原稀釋平均股數(千股) | 72,590 | 70,629 | 69,540 | 63,068 | 63,029 | 62,978 | 62,848 | 62,987 | 62,602 | 51,580 |
EBITDA(千元) | 57,762 | -7,579 | -20,025 | -21,168 | -15,353 | -17,531 | -18,825 | -20,311 | -20,174 | -22,893 |